Brief: Dynavax Technologies Q1 product revenues USD 43.451 million
02/05/2023 22:10
May 2 (Reuters) - Dynavax Technologies Q1 product revenues USD 43.451 million. * Q1 operating expenses USD 77.173 million * Q1 operating income USD -30.248 million * Q1 net income USD -24.332 million
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality